These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27777333)

  • 21. Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study.
    Ortonne JP; Nikkels AF; Reich K; Ponce Olivera RM; Lee JH; Kerrouche N; Sidou F; Faergemann J
    Br J Dermatol; 2011 Jul; 165(1):171-6. PubMed ID: 21707573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiseborrhoic effect of bituminosulfonates in acne vulgaris].
    Gloor M; Steingräber V; Friederich HC
    Hautarzt; 1973 Jul; 24(7):288-90. PubMed ID: 4146809
    [No Abstract]   [Full Text] [Related]  

  • 24. [Overcoming of seborrheic therapeutic problems in daily practice with Stepin and Stephalen].
    Krueger GA
    Hippokrates; 1967 Dec; 38(24):975-9. PubMed ID: 4238026
    [No Abstract]   [Full Text] [Related]  

  • 25. Qualitative, not quantitative, alterations of sebum important in seborrhoeic dermatitis.
    Burkhart CG; Burkhart CN
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):441; author reply 441. PubMed ID: 19335733
    [No Abstract]   [Full Text] [Related]  

  • 26. Adult female acne treated with spironolactone: a retrospective data review of 70 cases.
    Isvy-Joubert A; Nguyen JM; Gaultier A; Saint-Jean M; Le Moigne M; Boisrobert E; Khammari A; Dreno B
    Eur J Dermatol; 2017 Aug; 27(4):393-398. PubMed ID: 28862134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Low-dose isotretinoin for treatment of chronic discoid lupus in women of childbearing age].
    Pérez-Crespo M; Bañuls J; Mataix J; Lucas A
    Actas Dermosifiliogr; 2008; 99(6):498-9. PubMed ID: 18558067
    [No Abstract]   [Full Text] [Related]  

  • 28. Disseminate and recurrent infundibulofolliculitis: response to isotretinoin.
    Aroni K; Grapsa A; Agapitos E
    J Drugs Dermatol; 2004; 3(4):434-5. PubMed ID: 15303788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and relapse rates of different Isotretinoin dosages in treating acne vulgaris: systemic review.
    Tan TH; Hallett R; Yesudian PD
    Clin Med (Lond); 2016 Jun; 16 Suppl 3(Suppl 3):s34. PubMed ID: 27252338
    [No Abstract]   [Full Text] [Related]  

  • 30. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
    Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
    Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case studies.
    Bikowski JB
    Cutis; 2006 Feb; 77(2 Suppl):17-21. PubMed ID: 16566284
    [No Abstract]   [Full Text] [Related]  

  • 33. Isotretinoin treatment for folliculitis decalvans: a retrospective case-series study.
    Aksoy B; Hapa A; Mutlu E
    Int J Dermatol; 2018 Feb; 57(2):250-253. PubMed ID: 29313960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial.
    Kim TW; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim MB; Song KH; Lee SK; Seo JK; Lee D; Kim BS
    Acta Derm Venereol; 2013 Sep; 93(5):557-61. PubMed ID: 23388687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis].
    Peyrí J; Lleonart M;
    Actas Dermosifiliogr; 2007 Sep; 98(7):476-82. PubMed ID: 17669302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
    Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of oral isotretinoin in the treatment of moderate to severe seborrheic dermatitis: a retrospective study.
    Yanfei Z; Xiaoying N; Dingwei Z; Wei W; Jianwen R
    Int J Dermatol; 2023 Jun; 62(6):759-763. PubMed ID: 36789995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical pimecrolimus in the treatment of seborrheic dermatitis.
    Brownell I; Quan LT; Hsu S
    Dermatol Online J; 2003 Aug; 9(3):13. PubMed ID: 12952760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABSORICA (isotretinoin): a new form.
    Scheinfeld N
    Skinmed; 2013; 11(2):117-9. PubMed ID: 23745231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.